Prostate Cancer — Year in Review Series on Relevant New Datasets and Advances
About this episode
Dr Andrew J Armstrong and Dr Scott T Tagawa discuss therapy selection and major advances in prostate cancer treatment over the past year.
Dr Andrew J Armstrong from the Duke Cancer Institute in Durham, North Carolina, and Dr Scott T Tagawa from Weill Cornell Medicine Meyer Cancer Center in New York, New York, discuss the selection and sequencing of therapy for patients with prostate cancer and summarize major advances in the treatment landscape over the past year. CME information and select publications here .
More episodes of Prostate Cancer Update
- Metastatic Bladder Cancer — Rapid Case Review Issue 4
- AKT Inhibition in Prostate Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Genitourinary Cancers Symposium
- Metastatic Bladder Cancer — Rapid Case Review Issue 3
- Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Genitourinary Cancers Symposium
- Urothelial Bladder Cancer — Microlearning Activity 2 with Dr Terence Friedlander: ESMO Congress 2025 Review
- Metastatic Bladder Cancer — Rapid Case Review Issue 2
Explore listener stats, chart rankings, contacts and more on the Prostate Cancer Update podcast page.